It is assumed that the underlying mechanisms in COVID-19, such as acute respiratory distress syndrome, extensive lung damage, and cytokine release storm, such as IL-1, IL-6, and TNF-α leading to interstitial pulmonary inflammation (Wang et al., 2020), could have impacts on these autoimmune disorders. This evidence concerns the gene TNF and COVID-19.